Baylor, GE Medical Launch ‘The Health Channel’

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

HOUSTON-GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

HOUSTON—GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

The new service, called The Health Channel, is directed by Baylor College of Medicine and Texas Children’s Hospital, and is available through GE Medical Systems’ TiP-TV satellite broadcast network. Currently, 1,600 health care facilities in the US, Canada, and Europe provide TiP-TV programming to their staff.

Programs are developed and accredited by Baylor in cooperation with a consortium of leading academic medical institutions, including The Cleveland Clinic Foundation, Duke University Medical Center, the Mayo Clinic, M.D. Anderson Cancer Center, and others.

Programs repeat frequently to accommodate various day and night staff schedules. The channel runs 24 hours a day, 7 days a week, with new programming offered every week. A bi-monthly broadcast guide lists dates and times.

The monthly subscription rate for The Health Channel varies depending on hospital bed size and can range from $750 to $3,000. Hospitals can subscribe by calling toll free 1-877-GE TiPTV (1-877-438-4788). More information on the new service is available at the Channel’s website, www.healthchannelweb.com.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content